Dallen Medical officials have filed its FDA 510(k) application for the Compressyn staple for small bone fixation, specifically in foot, ankle, and hand applications. With the company’s Compressyn band for sternal closure already FDA cleared, this application is part of the company’s plan to expand its Compressyn family of products.
“We are very pleased to get this submission in and are excited about the potential of our Compressyn technology to improve patient outcomes and thereby reduce costs to the healthcare system,” Dallen Medical president and CEO, David H. Mills states. “All of our investors are pleased with this milestone and the future opportunities for the Compressyn technology.”
Dallen Medical's patented Compressyn technology offers significant improvement over existing products by delivering superior fixation with compression in sternal closure, small bone, and sports med applications. This should result in better patient outcomes, resulting in cost savings and reductions in length of stay.
Latest from Today's Medical Developments
- Boston Scientific to acquire Penumbra, expanding cardiovascular portfolio
- Star Cutter introduces Double Pilot Reamer
- #80 Manufacturing Matters - Machining Strategies to Save Time and Improve your Process for MedTech Components with Kennametal Inc.
- Real-world parts and expert manufacturing advice
- Experts discuss the latest in toolholding technology
- How permanent magnets are powering medical innovation
- Forecasting the year ahead in design and manufacturing
- Tecomet, Orchid Orthopedic Solutions announce merger agreement
